0

Vaccine Research Market by End-user and Geography - Forecast and Analysis 2022-2026

  • Published: Jun 2022
  • Pages: 134
  • SKU: IRTNTR71157
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Safe and Secure SSL Encrypted

info
close
  • Single User:

    Quick and easy buy and download option

  • Enterprise:

    Flexible option - Complimentary customization included

2500 USD

The vaccine research market share is expected to increase to USD 13.34 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 8.36%.

This vaccine research market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers vaccine research market segmentation by end-user (public and private) and geography (North America, Europe, Asia, and Rest of World (ROW)). The vaccine research market report also offers information on several market vendors, including Abbott Laboratories, Astellas Pharma Inc., AstraZeneca Plc, Bavarian Nordic AS, Bharat Biotech Ltd., CanSino Biologics Inc., CSL Ltd., Daiichi Sankyo Co. Ltd., Emergent BioSolutions Inc., GlaxoSmithKline Plc, Inovio Pharmaceuticals Inc., Johnson and Johnson, Merck and Co. Inc., Mitsubishi Chemical Holdings Corp., Novavax Inc., Panacea Biotec Ltd., Pfizer Inc., Sanofi, Serum Institute of India Pvt. Ltd., and Takeda Pharmaceutical Co. Ltd. among others.

What will the Vaccine Research Market Size be During the Forecast Period?

Vaccine Research Market Size

Download the Free Report Sample to Unlock the Vaccine research Market Size for the Forecast Period and Other Important Statistics

 

Vaccine Research Market: Key Drivers, Trends, and Challenges

Based on our research output, there has been a neutral impact on the market growth during and post COVID-19 era. The high prevalence of infectious diseases is notably driving the vaccine research market growth, although factors such as the high cost of vaccine research, development, and manufacturing may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the vaccine research industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Vaccine Research Market Driver

  • The high prevalence of infectious diseases is one of the key drivers supporting the vaccine research market growth.
  • In developing countries, the impact of infectious diseases has often been devastating due to the poor healthcare infrastructure, leading to a high number of fatalities, particularly in the pediatric population, and hampering economic growth and development.
  • Due to the increasing incidence and prevalence of infectious diseases, vendors are heavily investing in the R&D of vaccines.
  • The need for novel vaccines to prevent several emerging and re-emerging infectious diseases, such as COVID-19, is increasing. In view of this, government and non-government organizations worldwide are increasing their research on novel vaccines for various micro-organisms. Such an increase in research activities will drive the vaccine research market growth during the forecast period.

Key Vaccine Research Market Trend

  • The adoption of AI to speed up the R&D of vaccines is one of the key vaccine research market trends fueling the market growth.
  • AI helps convert data into valuable knowledge to understand the disease to be treated, design better clinical trials, and speed up the way we design and develop vaccines.
  • AI tools help vaccine researchers uncover new biological insights with the aim of increasing R&D productivity.
  • AstraZeneca Plc uses AI across its R&D activities to collate, connect, and analyze different data and information. This helps the organization understand the disease better and identify drug targets with a higher probability of success.
  • AI is used for analyzing images in real-time and has helped researchers try to pick out genetic mutations and variations. This helps to find new variants or mutations in the virus. Such beneficiary attributes of adopting the AI will propel the vaccine research market growth during the forecast period.

Key Vaccine Research Market Challenge

  • The high cost of vaccine research, development, and manufacturing is one of the key factors challenging the vaccine research market growth.
  • According to a study conducted by CEPI, the cost of developing a single epidemic-causing infectious disease vaccine, right from the pre-clinical trial stage to the end of Phase IIa, was estimated to be $31-$68 million, assuming no risk of failure in clinical trials.
  • Vaccine manufacturing facilities incur significant fixed and ongoing maintenance costs, which can account for approximately $50-500 million per antigen, based on the automation, the complexity of design, segregation, utilities, and contamination controls.
  • Newer vaccines, such as those that use innovative technologies like mRNA, are more complex to produce than older ones, which contributes to their higher cost, which may limit the market growth.

This vaccine research market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global vaccine research market as a part of the global life science tools and services market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the vaccine research market during the forecast period.

Who are the Major Vaccine Research Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

 

  • Abbott Laboratories
  • Astellas Pharma Inc.
  • AstraZeneca Plc
  • Bavarian Nordic AS
  • Bharat Biotech Ltd.
  • CanSino Biologics Inc.
  • CSL Ltd.
  • Daiichi Sankyo Co. Ltd.
  • Emergent BioSolutions Inc.
  • GlaxoSmithKline Plc
  • Inovio Pharmaceuticals Inc.
  • Johnson and Johnson
  • Merck and Co. Inc.
  • Mitsubishi Chemical Holdings Corp.
  • Novavax Inc.
  • Panacea Biotec Ltd.
  • Pfizer Inc.
  • Sanofi
  • Serum Institute of India Pvt. Ltd.
  • Takeda Pharmaceutical Co. Ltd.

 

This statistical study of the vaccine research market encompasses successful business strategies deployed by the key vendors. The vaccine research market is fragmented and the vendors are deploying organic and inorganic growth strategies to compete in the market.

Product Insights and News

  • Bavarian-nordic.com - The company is involved in vaccine research for diseases such as smallpox, respiratory syncytial virus, SARS CoV2, and Immuno oncology. Some of the pipeline products are ABNCOV2, MVA BN freeze-dried, MVA BN RSV, and TAEK VAC.
  • Emergentbiosolutions.com - The company is involved in vaccine research for diseases such as chikungunya virus, influenza, Lassa fever, and Marburg virus. Some of the pipeline products are AV7909, CHIKV VLP, UniFlu, WEVEE VLP, and EBS Lassa.
  • Inovio.com - The company is involved in vaccine research for diseases such as Covid 19, HPV-associated diseases, and Immuno oncology. Some of the pipeline products are INO 4800, VGX 3100, and INO 4500.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The vaccine research market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Vaccine Research Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the vaccine research market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for Vaccine Research Market?

Vaccine Research Market Market segmentation by region

For more insights on the market share of various regions Request for a FREE sample now!

42% of the market's growth will originate from North America during the forecast period. The US and Canada are the key markets for vaccine research in North America. Market growth in this region will be faster than the growth of the market in Rest of World (ROW).

The strong prevalence of several infectious and non-infectious diseases will facilitate the vaccine research market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

The outbreak of COVID-19 had a positive impact on the regional market growth. Furthermore, the market has witnessed high demand for COVID-19 vaccines in North America due to the significantly high number of COVID-19 cases. Therefore, the high number of COVID-19 cases has driven the demand for COVID-19 vaccines, thereby accelerating the procurement of COVID-19 vaccines in the region. This, in turn, will drive the vaccine research market growth during the forecast period.

What are the Revenue-generating End-user Segments in the Vaccine Research Market?

Vaccine Research Market Segmentation

To gain further insights on the market contribution of various segments Request for a FREE sample

The vaccine research market share growth by the public segment will be significant during the forecast period. Following the outbreak of the highly deadly COVID-19 pandemic in early 2020 and its rapid spread across the world, countries scrambled to develop effective vaccines to counter the new and extremely virulent SARS-CoV-2 virus. Moreover, governments have largely funded and invested in each and every aspect, starting from the basic science and pre-clinical development to the clinical trials for these vaccines. The estimation of direct public spending on the R&D of COVID-19 vaccines differs significantly based on the range of sources examined and the timing of data collection. These factors of the public segment will drive the vaccine research market growth during the forecast period.

This report provides an accurate prediction of the contribution of all the segments to the growth of the vaccine research market size and actionable market insights on post COVID-19 impact on each segment.

 

Vaccine Research Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 8.36%

Market growth 2022-2026

$ 13.34 billion

Market structure

Fragmented

YoY growth (%)

7.15

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 42%

Key consumer countries

US, Canada, UK, Germany, and China

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

Abbott Laboratories, Astellas Pharma Inc., AstraZeneca Plc, Bavarian Nordic AS, Bharat Biotech Ltd., CanSino Biologics Inc., CSL Ltd., Daiichi Sankyo Co. Ltd., Emergent BioSolutions Inc., GlaxoSmithKline Plc, Inovio Pharmaceuticals Inc., Johnson and Johnson, Merck and Co. Inc., Mitsubishi Chemical Holdings Corp., Novavax Inc., Panacea Biotec Ltd., Pfizer Inc., Sanofi, Serum Institute of India Pvt. Ltd., and Takeda Pharmaceutical Co. Ltd.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Vaccine Research Market Report?

  • CAGR of the market during the forecast period 2022-2026
  • Detailed information on factors that will drive vaccine research market growth during the next five years
  • Precise estimation of the vaccine research market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the vaccine research industry across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of the market's competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of vaccine research market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 06: Executive Summary – Chart on Incremental Growth
    • Exhibit 07: Executive Summary – Data Table on Incremental Growth
    • Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 09: Parent market
    • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 12: Market segments
  • 3.3 Market size 2021
    • 3.4 Market outlook: Forecast for 2021-2026
      • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
      • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

    4 Five Forces Analysis

    • 4.1 Five forces summary
      • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
    • 4.2 Bargaining power of buyers
      • Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
    • 4.3 Bargaining power of suppliers
      • Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
    • 4.4 Threat of new entrants
      • Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
    • 4.5 Threat of substitutes
      • Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
    • 4.6 Threat of rivalry
      • Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
    • 4.7 Market condition
      • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

    5 Market Segmentation by End-user

    • 5.1 Market segments
      • Exhibit 24: Chart on End-user - Market share 2021-2026 (%)
      • Exhibit 25: Data Table on End-user - Market share 2021-2026 (%)
    • 5.2 Comparison by End-user
      • Exhibit 26: Chart on Comparison by End-user
      • Exhibit 27: Data Table on Comparison by End-user
    • 5.3 Public - Market size and forecast 2021-2026
      • Exhibit 28: Chart on Public - Market size and forecast 2021-2026 ($ million)
      • Exhibit 29: Data Table on Public - Market size and forecast 2021-2026 ($ million)
      • Exhibit 30: Chart on Public - Year-over-year growth 2021-2026 (%)
      • Exhibit 31: Data Table on Public - Year-over-year growth 2021-2026 (%)
    • 5.4 Private - Market size and forecast 2021-2026
      • Exhibit 32: Chart on Private - Market size and forecast 2021-2026 ($ million)
      • Exhibit 33: Data Table on Private - Market size and forecast 2021-2026 ($ million)
      • Exhibit 34: Chart on Private - Year-over-year growth 2021-2026 (%)
      • Exhibit 35: Data Table on Private - Year-over-year growth 2021-2026 (%)
    • 5.5 Market opportunity by End-user
      • Exhibit 36: Market opportunity by End-user ($ million)

    6 Customer Landscape

    • 6.1 Customer landscape overview
      • Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    7 Geographic Landscape

    • 7.1 Geographic segmentation
      • Exhibit 38: Chart on Market share by geography 2021-2026 (%)
      • Exhibit 39: Data Table on Market share by geography 2021-2026 (%)
    • 7.2 Geographic comparison
      • Exhibit 40: Chart on Geographic comparison
      • Exhibit 41: Data Table on Geographic comparison
    • 7.3 North America - Market size and forecast 2021-2026
      • Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
      • Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
    • 7.4 Europe - Market size and forecast 2021-2026
      • Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
      • Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
    • 7.5 Asia - Market size and forecast 2021-2026
      • Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
      • Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
    • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
      • Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
      • Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
    • 7.7 US - Market size and forecast 2021-2026
      • Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
      • Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
    • 7.8 UK - Market size and forecast 2021-2026
      • Exhibit 62: Chart on UK - Market size and forecast 2021-2026 ($ million)
      • Exhibit 63: Data Table on UK - Market size and forecast 2021-2026 ($ million)
      • Exhibit 64: Chart on UK - Year-over-year growth 2021-2026 (%)
      • Exhibit 65: Data Table on UK - Year-over-year growth 2021-2026 (%)
    • 7.9 Germany - Market size and forecast 2021-2026
      • Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
      • Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
    • 7.10 Canada - Market size and forecast 2021-2026
      • Exhibit 70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
      • Exhibit 71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
      • Exhibit 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
      • Exhibit 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
    • 7.11 China - Market size and forecast 2021-2026
      • Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
      • Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)
    • 7.12 Market opportunity by geography
      • Exhibit 78: Market opportunity by geography ($ million)

    8 Drivers, Challenges, and Trends

    • 8.1 Market drivers
      • 8.2 Market challenges
        • 8.3 Impact of drivers and challenges
          • Exhibit 79: Impact of drivers and challenges in 2021 and 2026
        • 8.4 Market trends

          9 Vendor Landscape

          • 9.1 Overview
            • 9.2 Vendor landscape
              • Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
            • 9.3 Landscape disruption
              • Exhibit 81: Overview on factors of disruption
            • 9.4 Industry risks
              • Exhibit 82: Impact of key risks on business

            10 Vendor Analysis

            • 10.1 Vendors covered
              • Exhibit 83: Vendors covered
            • 10.2 Market positioning of vendors
              • Exhibit 84: Matrix on vendor position and classification
            • 10.3 Bavarian Nordic AS
              • Exhibit 85: Bavarian Nordic AS - Overview
              • Exhibit 86: Bavarian Nordic AS - Product / Service
              • Exhibit 87: Bavarian Nordic AS - Key news
              • Exhibit 88: Bavarian Nordic AS - Key offerings
            • 10.4 CSL Ltd.
              • Exhibit 89: CSL Ltd. - Overview
              • Exhibit 90: CSL Ltd. - Business segments
              • Exhibit 91: CSL Ltd. - Key news
              • Exhibit 92: CSL Ltd. - Key offerings
              • Exhibit 93: CSL Ltd. - Segment focus
            • 10.5 Emergent BioSolutions Inc.
              • Exhibit 94: Emergent BioSolutions Inc. - Overview
              • Exhibit 95: Emergent BioSolutions Inc. - Product / Service
              • Exhibit 96: Emergent BioSolutions Inc. - Key news
              • Exhibit 97: Emergent BioSolutions Inc. - Key offerings
            • 10.6 GlaxoSmithKline Plc
              • Exhibit 98: GlaxoSmithKline Plc - Overview
              • Exhibit 99: GlaxoSmithKline Plc - Business segments
              • Exhibit 100: GlaxoSmithKline Plc - Key news
              • Exhibit 101: GlaxoSmithKline Plc - Key offerings
              • Exhibit 102: GlaxoSmithKline Plc - Segment focus
            • 10.7 Inovio Pharmaceuticals Inc.
              • Exhibit 103: Inovio Pharmaceuticals Inc. - Overview
              • Exhibit 104: Inovio Pharmaceuticals Inc. - Product / Service
              • Exhibit 105: Inovio Pharmaceuticals Inc. - Key offerings
            • 10.8 Johnson and Johnson
              • Exhibit 106: Johnson and Johnson - Overview
              • Exhibit 107: Johnson and Johnson - Business segments
              • Exhibit 108: Johnson and Johnson - Key news
              • Exhibit 109: Johnson and Johnson - Key offerings
              • Exhibit 110: Johnson and Johnson - Segment focus
            • 10.9 Merck and Co. Inc.
              • Exhibit 111: Merck and Co. Inc. - Overview
              • Exhibit 112: Merck and Co. Inc. - Business segments
              • Exhibit 113: Merck and Co. Inc. - Key news
              • Exhibit 114: Merck and Co. Inc. - Key offerings
              • Exhibit 115: Merck and Co. Inc. - Segment focus
            • 10.10 Novavax Inc.
              • Exhibit 116: Novavax Inc. - Overview
              • Exhibit 117: Novavax Inc. - Product / Service
              • Exhibit 118: Novavax Inc. - Key offerings
            • 10.11 Pfizer Inc.
              • Exhibit 119: Pfizer Inc. - Overview
              • Exhibit 120: Pfizer Inc. - Product / Service
              • Exhibit 121: Pfizer Inc. - Key news
              • Exhibit 122: Pfizer Inc. - Key offerings
            • 10.12 Sanofi
              • Exhibit 123: Sanofi - Overview
              • Exhibit 124: Sanofi - Business segments
              • Exhibit 125: Sanofi - Key news
              • Exhibit 126: Sanofi - Key offerings
              • Exhibit 127: Sanofi - Segment focus

            11 Appendix

            • 11.1 Scope of the report
              • 11.2 Inclusions and exclusions checklist
                • Exhibit 128: Inclusions checklist
                • Exhibit 129: Exclusions checklist
              • 11.3 Currency conversion rates for US$
                • Exhibit 130: Currency conversion rates for US$
              • 11.4 Research methodology
                • Exhibit 131: Research methodology
                • Exhibit 132: Validation techniques employed for market sizing
                • Exhibit 133: Information sources
              • 11.5 List of abbreviations
                • Exhibit 134: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              TechnavioINFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases
              Technavio

              TechnavioDATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts
              Technavio

              TechnavioREPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape
              Interested in this report?
              Get your sample now!
              Vaccine research Market market growth will increase by $13.34 bn during 2022-2026.
              The vaccine research market market is expected to grow at a CAGR of 8.36% during 2022-2026.
              Technavio has segmented the vaccine research market market by end-user (Public and Private) and geography (North America, Europe, Asia, Rest of World (ROW), and MEA).
              Abbott Laboratories, Astellas Pharma Inc., AstraZeneca Plc, Bavarian Nordic AS, Bharat Biotech Ltd., CanSino Biologics Inc., CSL Ltd., Daiichi Sankyo Co. Ltd., Emergent BioSolutions Inc., GlaxoSmithKline Plc, Inovio Pharmaceuticals Inc., Johnson and Johnson, Merck and Co. Inc., Mitsubishi Chemical Holdings Corp., Novavax Inc., Panacea Biotec Ltd., Pfizer Inc., Sanofi, Serum Institute of India Pvt. Ltd., Takeda Pharmaceutical Co. Ltd. are a few of the key vendors in the vaccine research market market.
              North America will register the highest growth rate of 42% among the other regions. Therefore, the vaccine research market market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
              The key factors driving the vaccine research market market growth are:
              • High prevalence of infectious diseases
              • Adoption of AI to speed up the R and D of vaccines
              The vaccine research market market vendors should focus on grabbing business opportunities from the public segment as it accounted for the largest market share in the base year.
              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?
              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis

              Certified ISO 9001 : 2015

              We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

              We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

              Safe and Secure SSL Encrypted
              Technavio

              info
              close
              • Single User:

                Quick and easy buy and download option

              • Enterprise:

                Flexible option - Complimentary customization included

              2500 USD

              Technavio Get the report (PDF) sent to your email within minutes.

              Subscribe & Save

              Get lifetime access to our
              Technavio Insights

              Customized Report as per your Business Needs

              • Our analysts will work directly with you and understand your needs
              • Get data on specified regions or segments, competitor and Vendors
              • Data will be formatted and presented as per your requirements
              • We offer $1000 worth of FREE customization at the time of purchase

              Let us help you make report more suited to your requirements.

              • Get a competitive breakdown as per your niche industry
              • Customize the data with various metrics that meet your business prerequisite
              • Understand Revenue Sources, Customers and many more
              • Details on Market Share
              • These customizations are done in a short amount of time by our analysts and industry experts
              Technavio
              Enquire Before Buying
              17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>